# K211801: SPRINT PNS System

- Pathway: 510(k) (Traditional)
- Applicant: Spr Therapeutics, Inc.
- Decided: Oct 13, 2021 after 125 days
- Product code: NHI (Stimulator, Nerve, Electrical, Percutaneous (Pens), For Pain Relief)
- Device class: 2
- Regulation: 21 CFR 882.5890
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
Longest line of descent: 10 generations back to K881114 (1988). 24 ancestors in all.
1 later device descends from it; 1 cites it directly.
0 of 26 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- K202660: SPRINT PNS System, Spr Therapeutics, Inc. (2021) Summary page 4.
- K061166: Deepwave Percutaneous Neuromodulation Pain Therapy System, Biowave Corporation (2006) Summary page 4.

## Most influential descendants
- K223306: SPRINT Peripheral Nerve Stimulation (PNS) System (2023), 0 descendants of its own

## Indications for use
The SPRINT PNS System is indicated for up to 60 days for: • Symptomatic relief of chronic, intractable pain, post-surgical and post-traumatic acute pain; • Symptomatic relief of post-traumatic pain; • Symptomatic relief of post-operative pain. The SPRINT PNS System is not intended to treat pain in the region innervated by the cranial and facial nerves.

Source page: https://510kreport.com/device/K211801
Methodology: https://510kreport.com/methodology